NCT06868732 2026-03-30
Evaluation of JSKN016 Combination Therapy in Subjects With NSCLC
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 1 Recruiting
Clinical Trials
4 trialsNCT05215067 2025-03-12
A Phase II Trial of AK104 in Advanced Non-Small Cell Lung Cancer
Akeso
Phase 2 Active not recruiting
NCT06775483 2025-01-15
Evaluation of JSKN016 in the Treatment of Advanced Non-small Cell Lung Cance： a Phase II Clinical Study
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 2 Not yet recruiting
NCT05001724 2023-04-25
KN046 Plus Lenvatinib in Subject With Advanced Non-Small Cell Lung Cancer in the Failure of Anti-PD-(L)1 Agent
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 2/3 Terminated